150 related articles for article (PubMed ID: 31119732)
1. Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: short report from a longitudinal study.
Mitchell E; Frith J; Newton J
Br J Haematol; 2019 Sep; 186(5):777-781. PubMed ID: 31119732
[TBL] [Abstract][Full Text] [Related]
2. Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross-sectional study.
Towner S; Berger ZE; Titman P; New HV; Theodore K; Brown G; Sibson KR
Br J Haematol; 2020 May; 189(3):534-542. PubMed ID: 31978938
[TBL] [Abstract][Full Text] [Related]
3. Fatigue in adult patients with primary immune thrombocytopenia.
Newton JL; Reese JA; Watson SI; Vesely SK; Bolton-Maggs PH; George JN; Terrell DR
Eur J Haematol; 2011 May; 86(5):420-9. PubMed ID: 21323737
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in children and adolescents with immune thrombocytopenia.
Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
[TBL] [Abstract][Full Text] [Related]
5. Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura.
Blatt J; Weston B; Gold S
Pediatr Hematol Oncol; 2010 Feb; 27(1):65-7. PubMed ID: 20121557
[TBL] [Abstract][Full Text] [Related]
6. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts.
Cohen YC; Djulbegovic B; Shamai-Lubovitz O; Mozes B
Arch Intern Med; 2000 Jun; 160(11):1630-8. PubMed ID: 10847256
[TBL] [Abstract][Full Text] [Related]
7. Concurrent celiac disease, idiopathic thrombocytopenic purpura and autoimmune thyroiditis: a case report.
Dogan M; Sal E; Akbayram S; Peker E; Cesur Y; Oner AF
Clin Appl Thromb Hemost; 2011; 17(6):E13-6. PubMed ID: 20682594
[TBL] [Abstract][Full Text] [Related]
8. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
10. Fatigue perception in a cohort of children with chronic immune thrombocytopenia and their caregivers using the PedsQL MFS: Real-life multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Lassandro G; Palmieri VV; Barone A; Farruggia P; Giona F; Licciardello M; Marinoni M; Marzollo A; Notarangelo LD; Palumbo G; Ramenghi U; Russo G; Saracco P; Spinelli M; Tolva A; Tornesello A; Palladino V; Noviello D; Giordano P
Pediatr Blood Cancer; 2021 Mar; 68(3):e28840. PubMed ID: 33274837
[TBL] [Abstract][Full Text] [Related]
11. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
[TBL] [Abstract][Full Text] [Related]
12. Fatigue in immune thrombocytopenia.
Hill QA; Newland AC
Br J Haematol; 2015 Jul; 170(2):141-9. PubMed ID: 25823426
[TBL] [Abstract][Full Text] [Related]
13. Comparison of idiopathic thrombocytopenic purpura in children between 3 months and 2 years versus 2-5 years.
Kalyoncu D; Yildirmak Y; Cetinkaya F
Pediatr Blood Cancer; 2009 May; 52(5):656-8. PubMed ID: 19117072
[TBL] [Abstract][Full Text] [Related]
14. Vascular dementia in patients with immune thrombocytopenic purpura.
Ahn YS; Horstman LL; Jy W; Jimenez JJ; Bowen B
Thromb Res; 2002 Sep; 107(6):337-44. PubMed ID: 12565721
[TBL] [Abstract][Full Text] [Related]
15. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
16. Mean Platelet Volume, Platelet Distribution Width, and Platelet Count, in Connection with Immune Thrombocytopenic Purpura and Essential Thrombocytopenia.
Lee E; Kim M; Jeon K; Lee J; Lee JS; Kim HS; Kang HJ; Lee YK
Lab Med; 2019 Jul; 50(3):279-285. PubMed ID: 30726936
[TBL] [Abstract][Full Text] [Related]
17. Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden.
Frith J; Watson S; Bolton Maggs PH; Newton JL
Eur J Haematol; 2012 Mar; 88(3):224-8. PubMed ID: 22044734
[TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report.
Horino T; Sasaoka A; Takao T; Taguchi T; Maruyama H; Ito H; Takemoto S; Taguchi H; Hashimoto K
Clin Rheumatol; 2005 Nov; 24(6):641-4. PubMed ID: 15864685
[TBL] [Abstract][Full Text] [Related]
19. Jianpi Yiqi Shexue ameliorates immune thrombocytopenia related fatigue by regulating mitochondrial function.
Zhang Y; Wang J; Gao J; Guo M; Chen H; Liu J; Li L; Liao J; Chen X; Lang H
Ann Palliat Med; 2021 Jan; 10(1):156-168. PubMed ID: 33440960
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.
Rossi D; De Paoli L; Franceschetti S; Capello D; Vendramin C; Lunghi M; Conconi A; Magnani C; Gaidano G
Br J Haematol; 2007 Jul; 138(2):249-52. PubMed ID: 17535272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
